Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & Administrative
Others
Ratios

Cogent Biosciences (COGT) EPS (Weighted Average and Diluted) (2021)

Cogent Biosciences (COGT) has 1 years of EPS (Weighted Average and Diluted) data on record, last reported at -$0.62 in Q4 2021.

  • For Q4 2021, EPS (Weighted Average and Diluted) changed N/A year-over-year to -$0.62; the TTM value through Sep 2021 reached -$0.49, changed N/A, while the annual FY2025 figure was -$2.16, 11.34% down from the prior year.
  • EPS (Weighted Average and Diluted) reached -$0.62 in Q4 2021 per COGT's latest filing, down from -$0.49 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at -$0.43 in Q2 2021 and bottomed at -$0.62 in Q4 2021.